December 2020 FDA Recall Vumerity by Biogen Ma Inc.
D-0148-2021 - Failed dissolution specifications

This Class II drug recall was voluntarily initiated by Biogen Ma Inc. on December 9, 2020 for the product Vumerity. The FDA reported the reason for recall as failed dissolution specifications. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0148-2021

Reason for Recall
Failed dissolution specifications: out-of-specification test results observed during the buffer stage dissolution testing.
Initiated
12-09-2020
Reported
12-23-2020
Quantity
5,307 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Vumerity (diroximel fumarate) delayed-release capsule, 231 mg, packaged in a) 106-count bottle, b)120-count bottle, Rx only, Manufactured for: Biogen Inc., Cambridge, MA 02142, NDC 64406-020-01

Batch or Lot Expiration Information

Lot# : a) 101801, Exp 5/31/2021; 102826, Exp 6/21/2021; b) 101799, Exp 5/31/2021; 102362, Exp 6/21/2021